Direct‐acting antivirals for chronic hepatitis C

enfresMillions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs), e.g. sofosbuvir, are relatively new and expensive...enmshrfresDirect‐acting antivirals for chronic hepatitis C Background Millions of people...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jakobsen, Janus C. (VerfasserIn) , Weiss, Karl Heinz (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2017/09/18
In: The Cochrane database of systematic reviews
Year: 2017, Heft: 9
ISSN:1469-493X
DOI:10.1002/14651858.CD012143.pub3
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1002/14651858.CD012143.pub3
Verlag, Volltext: http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD012143.pub3/full
Volltext
Verfasserangaben:Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, Poropat G, Djurisic S, Weiss KH, Bjelakovic M, Bjelakovic G, Klingenberg SL, Liu JP, Nikolova D, Koretz RL, Gluud C

MARC

LEADER 00000caa a2200000 c 4500
001 1577395433
003 DE-627
005 20230426230615.0
007 cr uuu---uuuuu
008 180709s2017 xx |||||o 00| ||eng c
024 7 |a 10.1002/14651858.CD012143.pub3  |2 doi 
035 |a (DE-627)1577395433 
035 |a (DE-576)507395433 
035 |a (DE-599)BSZ507395433 
035 |a (OCoLC)1341013263 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jakobsen, Janus C.  |e VerfasserIn  |0 (DE-588)1162446722  |0 (DE-627)1026040450  |0 (DE-576)507394526  |4 aut 
245 1 0 |a Direct‐acting antivirals for chronic hepatitis C  |c Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, Poropat G, Djurisic S, Weiss KH, Bjelakovic M, Bjelakovic G, Klingenberg SL, Liu JP, Nikolova D, Koretz RL, Gluud C 
264 1 |c 2017/09/18 
300 |a 758 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.07.2018 
520 |a enfresMillions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs), e.g. sofosbuvir, are relatively new and expensive...enmshrfresDirect‐acting antivirals for chronic hepatitis C Background Millions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Numerous previous... 
700 1 |a Weiss, Karl Heinz  |d 1976-  |e VerfasserIn  |0 (DE-588)130069531  |0 (DE-627)489615465  |0 (DE-576)297980203  |4 aut 
773 0 8 |i Enthalten in  |t The Cochrane database of systematic reviews  |d Chichester : Wiley, 1996  |g (2017,9) Artikel-Nummer CD012143, 758 Seiten  |h Online-Ressource  |w (DE-627)37234965X  |w (DE-600)2121904-7  |w (DE-576)285828908  |x 1469-493X  |7 nnas  |a Direct‐acting antivirals for chronic hepatitis C 
773 1 8 |g year:2017  |g number:9  |g extent:758  |a Direct‐acting antivirals for chronic hepatitis C 
856 4 0 |u http://dx.doi.org/10.1002/14651858.CD012143.pub3  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD012143.pub3/full  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180709 
993 |a Article 
994 |a 2017 
998 |g 130069531  |a Weiss, Karl Heinz  |m 130069531:Weiss, Karl Heinz  |d 910000  |d 910100  |e 910000PW130069531  |e 910100PW130069531  |k 0/910000/  |k 1/910000/910100/  |p 9 
999 |a KXP-PPN1577395433  |e 301664746X 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"2017/09/18","dateIssuedKey":"2017"}],"relHost":[{"title":[{"subtitle":"CDSR","title_sort":"Cochrane database of systematic reviews","title":"The Cochrane database of systematic reviews"}],"language":["eng"],"note":["Gesehen am 15.04.25"],"recId":"37234965X","disp":"Direct‐acting antivirals for chronic hepatitis CThe Cochrane database of systematic reviews","titleAlt":[{"title":"CDSR"},{"title":"The Cochrane database for systematic reviews"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"(2017,9) Artikel-Nummer CD012143, 758 Seiten","issue":"9","year":"2017","extent":"758"},"pubHistory":["Nachgewiesen 1996 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"[1996?]-","publisher":"Wiley ; Update Software Ltd.","publisherPlace":"Chichester ; [Erscheinungsort nicht ermittelbar]"}],"id":{"zdb":["2121904-7"],"eki":["37234965X"],"issn":["1469-493X","1361-6137"]}}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1002/14651858.CD012143.pub3"],"eki":["1577395433"]},"language":["eng"],"title":[{"title_sort":"Direct‐acting antivirals for chronic hepatitis C","title":"Direct‐acting antivirals for chronic hepatitis C"}],"recId":"1577395433","note":["Gesehen am 09.07.2018"],"physDesc":[{"extent":"758 S."}],"name":{"displayForm":["Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, Poropat G, Djurisic S, Weiss KH, Bjelakovic M, Bjelakovic G, Klingenberg SL, Liu JP, Nikolova D, Koretz RL, Gluud C"]},"person":[{"given":"Janus C.","family":"Jakobsen","display":"Jakobsen, Janus C.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Weiss, Karl Heinz","family":"Weiss","given":"Karl Heinz"}]} 
SRT |a JAKOBSENJADIRECTACTI2017